Oral Ganciclovir in the Prevention of Cytomegalovirus Infection in Postkidney Transplant ''CMV at Risk'' Recipients: A Controlled, Comparative Study of Two Regimens (750 mg Bid and 500 mg Bid)

By Ahsan N.   Holman M.J.   Sonderbye L.   Langhoff E.   Yang H.C.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1383-1385

Elsevier

Access to resources Recommend Favorite

Preemptive and prophylactic ganciclovir therapy for CMV infection in heart transplant patients

By Paniagua M.J.   Crespo-Leiro M.G.   Rodriguez J.A.   Fojon S.   Zuniga M.C.   Canizares A.   Rey R.   Cuenca J.J.   Juffe A.   Castro-Beiras A.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2528-2529

Elsevier

Access to resources Recommend Favorite

Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study

By Snydman D.R.   Falagas M.E.   Avery R.   Perlino C.   Ruthazer R.   Freeman R.   Rohrer R.   Fairchild R.   O'Rourke E.   Hibberd P.   Werner B.G.  

Transplantation Proceedings, Vol. 33, Iss. 4, 2001-06 ,pp. : 2571-2575

Elsevier

Access to resources Recommend Favorite

Ramadan fast in kidney transplant recipients: a prospective comparative study

By Said T.   Nampoory M.R.N.   Haleem M.A.   Nair M.P.   Johny K.V.   Samhan M.   Al-Mousawi M.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2614-2616

Elsevier

Access to resources Recommend Favorite

Effective oral ganciclovir prophylaxis against cytomegalovirus disease in heart transplant recipients

By Mullen G.M.   Silver M.A.   Malinowska K.   Lawless C.E.   Lichtenberg R.C.   Barath P.C.   O'Keefe P.J.   Robinson J.A.   Yeldandi V.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4110-4112

Elsevier

Access to resources Recommend Favorite